Profile

Cover photo
117 followers|125,935 views
AboutPostsPhotosYouTube

Stream

PPD

Shared publicly  - 
 
Trend detection drives quality and efficiency with dynamic visualization dashboards in Preclarus®. http://bit.ly/1OhGRB6
1

PPD

Shared publicly  - 
 
PPD in the News: This is the second of a three-part series from PPD's Dirk Reitsma & Austin Combest on chronic lymphocytic leukemia, published in the Journal of Hematology Oncology Pharmacy. http://bit.ly/2jzCOH1
The Journal of Hematology Oncology Pharmacy is an independent, peer-reviewed journal founded in 2011 to provide hematology and oncology pharmacy practitioners and other healthcare professionals with highquality peer-reviewed information relevant to hematologic and oncologic conditions to help them optimize drug therapy for patients.
1

PPD

Shared publicly  - 
 
We understand that hiring the right talent to meet your needs is critical. Explore PPD FSP. http://bit.ly/2bcdTVj
1

PPD

Shared publicly  - 
 
PPD and ArisGlobal | A Pharmacovigilance Success Story. Read this new white paper to learn how we teamed up to decrease manual data entry of safety events. http://bit.ly/2iIFaXl
Current Landscape Biopharmaceutical companies rely on global contract research organizations to deliver post-marketing pharmacovigilance services and to provide safety surveillance and monitoring to meet regulatory requirements for approved products. Certain products may need formal risk evaluation and mitigation strategies (REMS) or a risk management plan (RMP), creating a need for outsourcing expertise. PPD continues to… Continue reading →
1

PPD

Shared publicly  - 
 
The drug regulatory environment in China poses many challenges and most stakeholders consider it to be one of the most difficult regulatory environments to understand and navigate. Download our new whitepaper to learn about the current environment and latest regulatory reforms in China: http://bit.ly/2hbmQV8
1

PPD

Shared publicly  - 
 
PPD® Laboratories met or exceeded expectations for biomarker and companion diagnostic development expertise for more than 95% of surveyed PPD clients. – ISR Reports http://bit.ly/1RDmKmw
2

PPD

Shared publicly  - 
 
PPD in the News: Click here to read the last of a three-part series from PPD's Dirk Reitsma & Austin Combest on chronic lymphocytic leukemia, published in the Journal of Hematology Oncology Pharmacy. http://bit.ly/2jehGXw
The Journal of Hematology Oncology Pharmacy is an independent, peer-reviewed journal founded in 2011 to provide hematology and oncology pharmacy practitioners and other healthcare professionals with highquality peer-reviewed information relevant to hematologic and oncologic conditions to help them optimize drug therapy for patients.
1

PPD

Shared publicly  - 
 
PPD in the News: Click here to read the first article in a three-part series from PPD's Dirk Reitsma & Austin Combest on chronic lymphocytic leukemia, published in the Journal of Hematology Oncology Pharmacy. http://bit.ly/2jefvmF
The Journal of Hematology Oncology Pharmacy is an independent, peer-reviewed journal founded in 2011 to provide hematology and oncology pharmacy practitioners and other healthcare professionals with highquality peer-reviewed information relevant to hematologic and oncologic conditions to help them optimize drug therapy for patients.
1

PPD

Shared publicly  - 
 
PPD's Mike Gold, Vice President of Global Product Development, discusses the benefits of smaller #clinicaltrials in Scientific American http://bit.ly/2j0XGqk
Huge medical trials are vital to testing novel drugs and other interventions—but smaller studies are also crucial
1

PPD

Shared publicly  - 
 
See what inspires us to help bring therapies to those in need. http://bit.ly/1BSa42K
Contact Services · Early Development Close · Clinical Development Close · Functional Service Partnerships · PPD® Laboratories Close; Post-Approval Close; PPD® Consulting Close; Technology, Innovation & Performance Close; Industry Expertise Close; Events · Post-approval services Post-Approval.
1

PPD

Shared publicly  - 
 
PPD® Laboratories' global biomarker lab coverage supports studies of all sizes.
1

PPD

Shared publicly  - 
 
PPD in the news: CEO David Simmons discusses real-world data with Evidera President Jon Williams in this Contract Pharma Q&A. http://ow.ly/Lcu13062Gd6
PPD's Evidera acquisition aims to help clients address the growing demand for evidence from regulators and payers
2
Story
Tagline
Helping Deliver Life-changing Therapies
Introduction

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 16,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health. For more information, visit www.ppdi.com.

Contact Information
Contact info
Phone
+1 910 251 0081
Fax
+1 910 762 5820